ROSEN, LEADING INVESTOR COUNSEL, Encourages PACS Group Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PACS

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of purchasers of PACS Group Inc. common stock related to its IPO and subsequent securities transactions, alleging misleading statements and fraudulent activities by the company [1][5]. Group 1: Lawsuit Details - The class action lawsuit pertains to PACS Group Inc. common stock purchased during the IPO on April 11, 2024, and securities bought between April 11, 2024, and November 5, 2024 [1]. - The lawsuit claims that PACS engaged in a scheme to submit false Medicare claims, which allegedly drove over 100% of the company's operating and net income from 2020 to 2023 [5]. - Additional allegations include billing for unnecessary therapies to Medicare and falsifying documentation related to licensure and staffing, leading to materially misleading statements about the company's business and prospects [5]. Group 2: Investor Actions - Investors who purchased PACS common stock may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must file a motion with the court by January 13, 2025, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors [4].